Toronto’s Drug Checking Service said in a report from last week that it is monitoring an emerging trend after a new opioid, known as cychlorphine, was found in three fake pharmaceutical opioid samples collected in Toronto’s downtown core and the city’s west end between Oct. 25 and 28.